SOPHARMASOPHARMASOPHARMA

SOPHARMA

No trades
See on Supercharts
Market capitalization
‪2.29 B‬PLN
‪211.77 M‬PLN
‪4.17 B‬PLN
‪40.03 M‬
Beta (1Y)

About SOPHARMA

CEO
Ognian Ivanov Donev
Headquarters
Sofia
Founded
1933
ISIN
BG11SOSOBT18
FIGI
BBG002976FB8
Sopharma AD engages in the provision of pharmaceutical business. Its operations include production and marketing of medical products, medicinal substances as well as dosage forms. It also involved in research, engineering, and implementation activities in the field of phytochemistry, chemistry, and pharmacy. The firm offers dermatological products, gastroenterological, as well as psychoneurological, antiallergic and others. The company was founded in 1933 and is headquartered in Sofia, Bulgaria.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SPH is 13.70 PLN — it has increased by 1.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange SOPHARMA stocks are traded under the ticker SPH.
SOPHARMA is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for SOPHARMA has a max estimate of 15.95 PLN and a min estimate of 15.95 PLN.
Yes, you can track SOPHARMA financials in yearly and quarterly reports right on TradingView.
SPH stock has fallen by 2.14% compared to the previous week, the month change is a 4.86% fall, over the last year SOPHARMA has showed a 1.41% increase.
SPH net income for the last quarter is ‪38.85 M‬ PLN, while the quarter before that showed ‪33.79 M‬ PLN of net income which accounts for 14.96% change. Track more SOPHARMA financial stats to get the full picture.
Today SOPHARMA has the market capitalization of ‪2.24 B‬, it has increased by 0.29% over the last week.
Like other stocks, SPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOPHARMA stock right from TradingView charts — choose your broker and connect to your account.
SPH reached its all-time high on Apr 29, 2020 with the price of 23.00 PLN, and its all-time low was 3.50 PLN and was reached on Sep 7, 2012.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SOPHARMA technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SOPHARMA stock shows the buy signal. See more of SOPHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SOPHARMA future price: according to them, SPH price has a max estimate of 15.94 PLN and a min estimate of 15.94 PLN. Read a more detailed SOPHARMA forecast: see what analysts think of SOPHARMA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOPHARMA EBITDA is ‪317.11 M‬ PLN, and current EBITDA margin is 8.05%. See more stats in SOPHARMA financial statements.